Log in
Enquire now
‌

US Patent 9579365 Therapeutic ribonucleases

Patent 9579365 was granted and assigned to Quintessence Biosciences on February, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Quintessence Biosciences
Quintessence Biosciences
Current Assignee
Quintessence Biosciences
Quintessence Biosciences
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9579365
Date of Patent
February 28, 2017
Patent Application Number
14686410
Date Filed
April 14, 2015
Patent Primary Examiner
‌
Tekchand Saidha
Patent abstract

The present invention relates to the use of ribonucleases (RNases) in the treatment or prevention of disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9579365 Therapeutic ribonucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.